
|Videos|July 23, 2013
Episode 5 - Current Therapeutic Strategies for Hemophilia
Advertisement
Systemic lupus erythematosus (SLE) is a complex autoimmune process with the potential to detrimentally impact every organ system in the human body. According to Dr. Michelle Petri, up to two-thirds of SLE cases are due to genetic predisposition, with SLE being more prevalent and severe among African- and Hispanic-Americans. The remaining one-third of cases may be attributed to environmental and hormonal components, with women being affected more than men in a 9:1 ratio. The implications of SLE are far-reaching, and it is important to develop a greater understanding of the disease to further improve current diagnostic and management strategies.
Advertisement
Related to this article

Amanda Velazquez, MD, discusses GLP-1 formulary strategies, overcoming prior authorization hurdles, and building scalable obesity care infrastructure.

Cepheid's Connie Savor, MD, MBA, explains where its 13-pathogen respiratory panel fits in diagnostic stewardship and antibiotic decisions.

At a roundtable in Cleveland, kidney experts said IgA nephropathy and FSGS often go unrecognized, calling for EHR flags and better referral channels.

Medicare drug price negotiations lowered out-of-pocket costs for some beneficiaries, but those reaching the annual Part D cap saw no direct savings.

Experts explain why access to specialty cancer care, open dialogue, and patient education are essential to building trust and making informed treatment decisions.

Medicaid expansion was associated with lower colorectal cancer mortality, with the largest reductions in Hispanic patients and stage IV disease.
Advertisement
Advertisement
Trending on AJMC
1
Medicare Drug Price Negotiations Yield Uneven Out-of-Pocket Savings
2
Rusfertide Keeps Working Where Hydroxyurea Fades: Andrew Kuykendall, MD
3
Lymphoma Outcomes Hinge on Oncology, Not Viral Load In People With HIV
4
CMS Rule Ends Medicaid, CHIP Funding for Pediatric Gender Care
5




















